News
MGRX
0.3841
-2.31%
-0.0091
Weekly Report: what happened at MGRX last week (0302-0306)?
Weekly Report · 4d ago
Mangoceuticals announces patent filing for MGX-0024
TipRanks · 03/06 21:10
Mangoceuticals Files PCT International Application To Secure Global Patent Protection For Antiviral Animal Feed And Drinking Water Additive Technology Powering MGX-0024
Benzinga · 03/06 21:02
Mangoceuticals Reports Zero Respiratory-Related Mortality in 29,000-Bird MGX-0024 Trials
Reuters · 03/06 21:00
MANGOCEUTICALS, INC. ANNOUNCES PCT PATENT FILING FOR MGX-0024 ANTIVIRAL TECHNOLOGY TO INCLUDE INHIBITING RESPIRATORY OR ORALLY ACQUIRED VIRUS INFECTION IN ANIMALS OR BIRDS
Reuters · 03/06 21:00
Weekly Report: what happened at MGRX last week (0223-0227)?
Weekly Report · 03/02 09:25
BRIEF-Mangoceuticals’ MGX-0024 Achieves Zero Respiratory-Related Mortality, Shows H5n1 Prophylactic Benefit
Reuters · 02/23 21:47
Mangoceuticals Highlights Promising MGX-0024 Poultry Antiviral Data
TipRanks · 02/23 21:42
Mangoceuticals Announces New Data From Its Proprietary Antiviral Compound MGX-0024
Benzinga · 02/23 21:17
Mangoceuticals Says MGX-0024 Cuts H5N1 Deaths and Eliminates Respiratory Mortality in Poultry Trials
Reuters · 02/23 21:05
MANGOCEUTICALS INC - MORTALITY REDUCED BY UP TO 60% IN PRE-TREATMENT GROUP
Reuters · 02/23 21:05
Weekly Report: what happened at MGRX last week (0216-0220)?
Weekly Report · 02/23 09:24
Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?
Benzinga · 02/20 20:40
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
TipRanks · 02/20 16:59
Nasdaq Gains 1%; PPL Posts In-Line Q4 Earnings
Benzinga · 02/20 16:52
Dow Rises Over 100 Points; US GDP Growth Slows In Q4
Benzinga · 02/20 15:24
Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model
Benzinga · 02/20 14:59
MANGOCEUTICALS SHARES RISE 81% ON STRONG SALES OF INJECTABLE TESTOSTERONE THERAPY
Reuters · 02/20 14:30
Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today
TipRanks · 02/20 14:09
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Benzinga · 02/20 12:05
More
Webull provides a variety of real-time MGRX stock news. You can receive the latest news about Mangoceuticals, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MGRX
Mangoceuticals, Inc. is focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx and is also focused on wellness solutions. It is advancing its proprietary antiviral compound MGX-0024. The Company offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. It has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.